Cargando…

Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale

OBJECTIVE: The objective of the study was to carry out validity and reliability of Type 1 Diabetes Stigma Assessment Scale (DSAS-1) in Turkish. METHODS: The methodological study was conducted between December 2017 and May 2019, with 147 patients with Type 1 diabetes who applied to the Endocrinology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Satil, Ece Mutlu, Arabaci, Leyla Baysan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833382/
https://www.ncbi.nlm.nih.gov/pubmed/36685628
http://dx.doi.org/10.14744/nci.2021.36937
_version_ 1784868227300458496
author Satil, Ece Mutlu
Arabaci, Leyla Baysan
author_facet Satil, Ece Mutlu
Arabaci, Leyla Baysan
author_sort Satil, Ece Mutlu
collection PubMed
description OBJECTIVE: The objective of the study was to carry out validity and reliability of Type 1 Diabetes Stigma Assessment Scale (DSAS-1) in Turkish. METHODS: The methodological study was conducted between December 2017 and May 2019, with 147 patients with Type 1 diabetes who applied to the Endocrinology, Internal Medicine policlinics of a Training and Research Hospital. The data were collected with the Introductory Information Form and DSAS-1. SPSS-22 and Mplus Version-7.4 were used for data analysis. Validity (group-back translation method, Polit and Beck technique, factor analysis, and known-group comparison and pilot study) and reliability (test-retest reliability, Cronbach’s alpha reliability coefficient, and item-total correlation) analyses were used. RESULTS: It was found that 94.7% of the content validity index of the items of the DSAS-1 was 0.80 or above; the scale can factorable (Kaiser-Meyer-Olkin=0.86) and it was determined that the scale was able to separate known groups; the scale confirmed the 3-factor structure according to confirmatory factor analysis; the factor loads varied between 0.34 and 0.87 and their level was suitable according to fit index criteria (CFI=0.90, TLI=0.89, RMSEA=0.069, SRMR=0.065, Chi-square/df=1.706); the test-retest reliability value (r) was above 0.82; Cronbach’s alpha coefficient of Turkish DSAS-1 was 0.89; and Cronbach’s alpha coefficient of subscales was, respectively, to be 0.81, 0.80, and 0.81. CONCLUSION: It was found that the DSAS-1 has validity and reliability in Turkish and is a suitable measurement tool to evaluate the stigma by the individuals with a diagnosis of Type 1 diabetes in Turkiye.
format Online
Article
Text
id pubmed-9833382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-98333822023-01-20 Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale Satil, Ece Mutlu Arabaci, Leyla Baysan North Clin Istanb Original Article OBJECTIVE: The objective of the study was to carry out validity and reliability of Type 1 Diabetes Stigma Assessment Scale (DSAS-1) in Turkish. METHODS: The methodological study was conducted between December 2017 and May 2019, with 147 patients with Type 1 diabetes who applied to the Endocrinology, Internal Medicine policlinics of a Training and Research Hospital. The data were collected with the Introductory Information Form and DSAS-1. SPSS-22 and Mplus Version-7.4 were used for data analysis. Validity (group-back translation method, Polit and Beck technique, factor analysis, and known-group comparison and pilot study) and reliability (test-retest reliability, Cronbach’s alpha reliability coefficient, and item-total correlation) analyses were used. RESULTS: It was found that 94.7% of the content validity index of the items of the DSAS-1 was 0.80 or above; the scale can factorable (Kaiser-Meyer-Olkin=0.86) and it was determined that the scale was able to separate known groups; the scale confirmed the 3-factor structure according to confirmatory factor analysis; the factor loads varied between 0.34 and 0.87 and their level was suitable according to fit index criteria (CFI=0.90, TLI=0.89, RMSEA=0.069, SRMR=0.065, Chi-square/df=1.706); the test-retest reliability value (r) was above 0.82; Cronbach’s alpha coefficient of Turkish DSAS-1 was 0.89; and Cronbach’s alpha coefficient of subscales was, respectively, to be 0.81, 0.80, and 0.81. CONCLUSION: It was found that the DSAS-1 has validity and reliability in Turkish and is a suitable measurement tool to evaluate the stigma by the individuals with a diagnosis of Type 1 diabetes in Turkiye. Kare Publishing 2022-12-12 /pmc/articles/PMC9833382/ /pubmed/36685628 http://dx.doi.org/10.14744/nci.2021.36937 Text en © Copyright 2022 by Istanbul Provincial Directorate of Health https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Satil, Ece Mutlu
Arabaci, Leyla Baysan
Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale
title Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale
title_full Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale
title_fullStr Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale
title_full_unstemmed Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale
title_short Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale
title_sort turkish validity and reliability of type-1 diabetes stigma assessment scale
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833382/
https://www.ncbi.nlm.nih.gov/pubmed/36685628
http://dx.doi.org/10.14744/nci.2021.36937
work_keys_str_mv AT satilecemutlu turkishvalidityandreliabilityoftype1diabetesstigmaassessmentscale
AT arabacileylabaysan turkishvalidityandreliabilityoftype1diabetesstigmaassessmentscale